Correction to: J Exp Clin Cancer Res 37, 14 (2018)
https://doi.org/10.1186/s13046-018-0681-y
Following publication of the original article [1], the authors identified some errors in Figs. 4, 5 and 6; specifically panels Fig. 4d, Fig. 5e, and Fig. 6h. The corrections do not change the results and conclusions of this paper.
The correct figures are given below.
Reference
Zhang, et al. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res. 2018;37:14.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article to which this update relates has been retracted. Please see the original publication for more detail: https://doi.org/10.1186/s13046-022-02580-2
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, Q., Song, G., Yao, L. et al. Correction to: miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res 39, 165 (2020). https://doi.org/10.1186/s13046-020-01655-2
Published:
DOI: https://doi.org/10.1186/s13046-020-01655-2